Molecular Matrix, Inc.
We founded Molecular Matrix in 2011. After seven years of rigorous research and development on our tissue regeneration technology, we received FDA clearance for our breakthrough bone regeneration medical device. We believe that medicine is a continuous quest to ensure that people receive the life saving or life-enhancing treatments they need to return to full life. Our mission is to create those treatments and provide them worldwide. We are dedicated to developing an innovative platform technology for tissue regeneration applications. Osteopoietic Systems™ is our first clinical solution to the need for value-driven and safe bone regeneration products.
Company details
Find locations served, office locations
- Business Type:
- Technology
- Industry Type:
- Medical Research
- Market Focus:
- Nationally (across the country)
- Year Founded:
- 2011
About Us
Molecular Matrix is dedicated to developing next generation osteobiologic technology.
Nearly a decade ago, Molecular Matrix developed a breakthrough tissue regeneration technology. This platform technology gave rise to our first clinical product, a bone graft substitute used in orthopedic surgery for real-time bone tissue regeneration.
Charles Lee, CEO, CSO, and inventor of the technology, introduces Osteo-P technology, which provides a broad platform for bone engineering. Our technology can be used to repair damaged or missing bone while addressing many of the limitations and side effects seen in the orthopedic reconstruction field. The advancements brought by our technology will yield superior bone regeneration products and procedures for orthopedic, spine, and trauma applications.
MMI is on a continuous quest to innovate in the biotechnology and biomedical fields. Our vision is to develop life-enhancing and life-saving treatments that will be available worldwide. Research and development at our headquarters is under way to expand the therapeutic applications of our core technology. Our scientists are optimizing the technology for multiple tissue regeneration applications, both in vivo and in vitro.
Collaboration is the key to advancing our knowledge of and innovation in the biomedical field. We want to partner with industry members and the scientific community to bring the best therapeutics to market. Industry members are welcome to contact us and discover how a partnership with Molecular Matrix can accelerate your research and development objectives. Research organizations and academic institutions are encouraged to share their research articles in osteobiologic science, which can be featured on our publications page, and work with us to investigate the potential of polymer technology in tissue regeneration. Our researchers are building an additional public resource featuring articles and applied science commentary in osteobiologics.